U.S Physical Therapy Gross Profit 2010-2024 | USPH

U.S Physical Therapy gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
U.S Physical Therapy Annual Gross Profit
(Millions of US $)
2023 $122
2022 $112
2021 $117
2020 $94
2019 $112
2018 $102
2017 $91
2016 $82
2015 $78
2014 $76
2013 $65
2012 $63
2011 $56
2010 $56
2009 $52
U.S Physical Therapy Quarterly Gross Profit
(Millions of US $)
2024-03-31 $28
2023-12-31 $31
2023-09-30 $28
2023-06-30 $32
2023-03-31 $31
2022-12-31 $28
2022-09-30 $27
2022-06-30 $31
2022-03-31 $27
2021-12-31 $27
2021-09-30 $30
2021-06-30 $34
2021-03-31 $26
2020-12-31 $29
2020-09-30 $30
2020-06-30 $19
2020-03-31 $16
2019-12-31 $27
2019-09-30 $27
2019-06-30 $31
2019-03-31 $27
2018-12-31 $25
2018-09-30 $26
2018-06-30 $27
2018-03-31 $23
2017-12-31 $24
2017-09-30 $21
2017-06-30 $25
2017-03-31 $21
2016-12-31 $19
2016-09-30 $20
2016-06-30 $23
2016-03-31 $20
2015-12-31 $22
2015-09-30 $19
2015-06-30 $21
2015-03-31 $17
2014-12-31 $19
2014-09-30 $19
2014-06-30 $22
2014-03-31 $17
2013-12-31 $16
2013-09-30 $16
2013-06-30 $18
2013-03-31 $15
2012-12-31 $14
2012-09-30 $15
2012-06-30 $17
2012-03-31 $16
2011-12-31 $10
2011-09-30 $14
2011-06-30 $17
2011-03-31 $15
2010-12-31 $14
2010-09-30 $15
2010-06-30 $16
2010-03-31 $12
2009-12-31 $13
2009-09-30 $13
2009-06-30 $14
2009-03-31 $12
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.588B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.911B 10.23
Quest Diagnostics (DGX) United States $16.016B 16.55
DaVita (DVA) United States $12.360B 15.35
Encompass Health (EHC) United States $8.670B 22.19
Chemed (CHE) United States $8.544B 26.48
Elanco Animal Health (ELAN) United States $8.401B 21.80
Option Care Health (OPCH) United States $5.051B 19.12
RadNet (RDNT) United States $4.321B 89.99
Amedisys (AMED) United States $3.141B 22.25
LifeStance Health (LFST) United States $2.871B 0.00
Astrana Health (ASTH) United States $2.188B 29.59
Addus HomeCare (ADUS) United States $1.812B 25.92
Pennant (PNTG) United States $0.695B 36.70
Aveanna Healthcare Holdings (AVAH) United States $0.560B 0.00
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.028B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.012B 0.00
Novo Integrated Sciences (NVOS) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00